Kannalife Sciences CEO Dean Petkanas to Provide Presentation on Industry Advancement at 2018 Cannabinoids in Medicine Summit
27 avr. 2018 10h00 HE
|
Kannalife Sciences, Inc.
NEW YORK, April 27, 2018 (GLOBE NEWSWIRE) -- Kannalife Sciences, Inc. (“Kannalife”), a phyto-medical company, announced today that the Company’s CEO Dean Petkanas will be presenting at the 2018...
Medical Marijuana, Inc. Portfolio Investment Company, Kannalife Sciences, Inc. Notified of DEA Clearance for Import of High-Purity, Pharmaceutical-Grade Cannabidiol (CBD)
01 mars 2016 09h00 HE
|
Medical Marijuana Inc
SAN DIEGO, March 01, 2016 (GLOBE NEWSWIRE) -- Medical Marijuana, Inc. (OTC Pink:MJNA) is pleased to announce that the Company’s portfolio investment company, Kannalife Sciences, Inc. (“Kannalife”),...
Medical Marijuana, Inc. Portfolio Investment Company, Kannalife Sciences, Inc. Receives Publication Through American Chemical Society for KLS-13019, a Novel Cannabidiol-Derived Target Drug Candidate for Hepatic Encephalopathy
18 févr. 2016 09h00 HE
|
Medical Marijuana Inc
SAN DIEGO, Feb. 18, 2016 (GLOBE NEWSWIRE) -- Medical Marijuana, Inc. (OTC Pink:MJNA) is pleased to announce that the Company’s portfolio investment company, Kannalife Sciences, Inc. (“Kannalife”),...
Kannalife Sciences Announces Publication of “Discovery of KLS-13019, a Cannabidiol-Derived Neuroprotective Agent, With Improved Potency, Safety and Permeability”
16 févr. 2016 11h15 HE
|
Kannalife, Inc.
NEW YORK, Feb. 16, 2016 (GLOBE NEWSWIRE) -- Kannalife Sciences, Inc. (“Kannalife”), a Phyto-Medical Company, is pleased to announce the publication of the body of science behind KLS-13019, one of...
Kannalife Sciences Announces Publication of “Discovery of KLS-13019, a Cannabidiol-Derived Neuroprotective Agent, With Improved Potency, Safety and Permeability”
16 févr. 2016 11h15 HE
|
Kannalife, Inc.
NEW YORK, Feb. 16, 2016 (GLOBE NEWSWIRE) -- Kannalife Sciences, Inc. (“Kannalife”), a Phyto-Medical Company, is pleased to announce the publication of the body of science behind KLS-13019, one of...
Medical Marijuana, Inc.’s Portfolio Company KannaLife’s Spokesman, Ex-NFL Star Marvin Washington to Appear on ESPN’s Outside the Lines
18 déc. 2015 09h00 HE
|
Medical Marijuana Inc
NEW YORK, Dec. 18, 2015 (GLOBE NEWSWIRE) -- Medical Marijuana, Inc. (OTC Pink:MJNA) is proud to announce to shareholders and the public that investment portfolio company KannaLife Sciences’...
Medical Marijuana, Inc's Portfolio Investment Company Kannalife Sciences Announces Publication of Its Global PCT Patent Covering Cannabidiol-like Neuroprotective Agents
14 août 2015 09h00 HE
|
Medical Marijuana Inc
SAN DIEGO, Aug. 14, 2015 (GLOBE NEWSWIRE) -- Medical Marijuana, Inc. portfolio investment company Kannalife Sciences, Inc. has announced the publication of its global WIPO/PCT Patent WO2015/106108A2...
Medical Marijuana, Inc.'s Video Statement on Investment Portfolio's Historic Accomplishments and Supporting the Science Behind Cannabis Legalization
15 juil. 2015 10h15 HE
|
Medical Marijuana Inc
SAN DIEGO, July 15, 2015 (GLOBE NEWSWIRE) -- "Honestly, if you and I would have sat here two or three years ago, people would be saying, 'I would never invest in marijuana stocks,'" states Andrew...
Photo Release -- Medical Marijuana, Inc.'s HempMeds & Investment Company KannaLife Sciences Gain Global News Attention at New York Cannabis Convention
23 juin 2015 13h55 HE
|
Medical Marijuana Inc
SAN DIEGO, June 23, 2015 (GLOBE NEWSWIRE) -- As New York prepares for access to medical cannabis, many entrepreneurs curious about establishing businesses in support of the historic statewide...
Medical Marijuana, Inc.'s HempMeds Participates in New York Cannabis World Congress & Business Expo
12 juin 2015 10h28 HE
|
Medical Marijuana Inc
SAN DIEGO, June 12, 2015 (GLOBE NEWSWIRE) -- The entrepreneurial spirit is thriving in New York. As the state prepares for medical cannabis availability, cultivation and dispensary licenses are...